Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Conditions
Hypertension
Interventions
DRUG

Daglutril

Trial Locations (130)

Unknown

Site 705, Bracken Ridge

Site 706, Caboolture

Site 700, Inala

Site 701, Kippa-Ring

Site 702, Melbourne

Site 703, Nedlands

Site 952, Haskovo

Site 955, Pleven

Site 951, Plovdiv

Site 956, Plovdiv

Site 950, Sofia

Site 953, Sofia

Site 954, Sofia

Site 957, Sofia

Site 402, Aalborg

Site 401, Ballerup Municipality

Site 403, Vejle

Site 850, Tallinn

Site 119, Aschaffenburg

Site 101, Bad Nauheim

Site 104, Bad Wörishofen

Site 106, Beckum

Site 110, Deidesheim

Site 107, Karlsruhe

Site 118, Kassel

Site 109, Krombach

Site 113, Ladenburg

Site 102, Leipzig

Site 112, Lollar

Site 114, Magdeburg

Site 111, Marburg

Site 105, Münster

Site 115, Niederstetten

Site 120, Rodgau Dudenhofen

Site 116, Vellmar

Site 103, Wiesbaden

Site 117, Wolmirstedt

Site 800, Budapest

Site 805, Budapest

Site 803, Gyöngyös

Site 801, Kecskemét

Site 804, Pécs

Site 802, Székesfehérvár

Site 300, Ashkelon

Site 306, Ashkelon

Site 304, Beersheba

Site 311, Haifa

Site 305, Jerusalem

Site 310, Kfar Saba

Site 303, Kiryat Ata

Site 308, Petah Tikva

Site 302, Tel Aviv

Site 301, Tel Litwinsky

Site 309, Tiberias

Site 932, Daugavpils

Site 930, Kuldīga

Site 931, Riga

Site 933, Riga

Site 934, Riga

Site 935, Riga

Site 920, Kaunas

Site 923, Klaipėda

Site 921, Vilnius

Site 600, Bratislava

Site 601, Bratislava

Site 607, Košice

Site 608, Košice

Site 602, Levice

Site 605, Lučenec

Site 603, Nové Zámky

Site 606, Vráble

Site 262, Addlestone

Site 229, Airdrie

Site 234, Alexandria

Site 245, Bangor

Site 241, Barrhead

Site 224, Bath

Site 240, Bath

Site 230, Bellshill

Site 243, Bexhill-on-Sea

Site 261, Bexhill-on-Sea

Site 255, Blackpool

Site 222, Blantyre

Site 232, Calderbank

Site 236, Chesterfield

Site 219, Chippenham

Site 256, Chippenham

Site 237, Co Tyrone

Site 216, Coatbridge

Site 238, Cornwall

Site 207, Coventry

Site 247, Cumbernauld

Site 208, Dumbarton

Site 235, East Horsley

Site 220, Ely

Site 257, Frome

Site 210, Glasgow

Site 221, Glasgow

Site 227, Glasgow

Site 233, Glasgow

Site 251, Glasgow

Site 201, Greenisland

Site 252, Helensburgh

Site 249, Hook

Site 226, Maidenhead

Site 246, Maidenhead

Site 213, Manchester

Site 244, Melksham

Site 259, Middlesex

Site 202, Motherwell

Site 206, Motherwell

Site 217, Motherwell

Site 239, Motherwell

Site 231, Paisley

Site 250, Paisley

Site 242, Penzance

Site 218, Plymouth

Site 223, Plymouth

Site 254, Reading

Site 212, Riddrie

Site 200, Royal Leamington Spa

Site 253, Sandy

Site 258, Sheffield

Site 205, Slough

Site 215, St Just

Site 211, Strathaven

Site 225, Swansea

Site 209, Thornhill

Site 248, Woking

Site 228, Wokingham

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00160212 - Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension | Biotech Hunter | Biotech Hunter